A carregar...
Novel agents in development for advanced non-small cell lung cancer
The identification of EGFR mutations and ALK rearrangements in nonsmall cell lung cancer (NSCLC) has led to the rapid development of targeted therapies and significant changes in the treatment paradigm. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and crizotinib are now...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4206610/ https://ncbi.nlm.nih.gov/pubmed/25342991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834014532510 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|